CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
A Case of Achieving Partial Remission with the Combination of Sorafenib and Nivolumab in a Patient with Hepatocellular Carcinoma Showing Disease Progression after Nivolumab Therapy
Sang Youn Hwang, Seon-Mi Lee, Jung Woo Im, Ki Jeong Jeon, Cheol-Won Choi, Kyung-Su Kim, Wan Jeon
J Liver Cancer. 2019;19(1):74-78.   Published online March 31, 2019
DOI: https://doi.org/10.17998/jlc.19.1.74

Excel Download

A Case of Achieving Partial Remission with the Combination of Sorafenib and Nivolumab in a Patient with Hepatocellular Carcinoma Showing Disease Progression after Nivolumab Therapy
Journal of Liver Cancer. 2019;19(1):74-78   Crossref logo
Link1 Link2 Link3

Long Term Remission and Cardiac Toxicity of a Combination of Ipilimumab and Nivolumab in a Patient With Metastatic Head and Neck Carcinoma After Progression Following Nivolumab Monotherapy
Frontiers in Oncology. 2019;9:   Crossref logo
Link1

Acute progression of aspergillosis in a patient with lung cancer receiving nivolumab
Respirology Case Reports. 2017;6(2):e00289   Crossref logo
Link1 Link2

Nivolumab
Reactions Weekly. 2018;1698(1):262-262   Crossref logo
Link1 Link2 Link3

Nivolumab
Reactions Weekly. 2017;1654(1):252-252   Crossref logo
Link1 Link2 Link3

Complete Response of Hepatocellular Carcinoma in a Patient With End-stage Liver Disease treated With Nivolumab: Whishful thinking or Possible?
American Journal of Gastroenterology. 2016;111(8):1208-1209   Crossref logo
Link1 Link2 Link3 Link4

Combination immune checkpoint inhibitor therapy nivolumab and ipilimumab associated with multiple endocrinopathies
Endocrinology, Diabetes & Metabolism Case Reports. 2018;   Crossref logo
Link1

Ipilimumab/nivolumab
Reactions Weekly. 2019;1754(1):202-202   Crossref logo
Link1 Link2 Link3

Long-term outcomes of patients with advanced hepatocellular carcinoma who achieved complete remission after sorafenib therapy
Clinical and Molecular Hepatology. 2015;21(3):287   Crossref logo
Link1 Link2

Rapid and partial remission of primary lesion but complicated by secondary fibrosis after treatment with nivolumab in a lung squamous carcinoma
Therapeutic Advances in Respiratory Disease. 2016;11(2):129-132   Crossref logo
Link1 Link2 Link3